|
CN103059014A
|
|
Novel heteroaryl amino derivative
|
|
CN103505441A
|
|
Oral solid preparation containing biguanides and acarbose and preparation method thereof
|
|
CN102688252A
|
|
Acarbose oral solid preparation composition and preparation method thereof
|
|
CN103381148A
|
|
Solid preparation including finasteride and preparation method thereof
|
|
CN103181923A
|
|
Medicinal preparation containing repaglinide and preparation of medicinal preparation
|
|
CN103181885A
|
|
Clopidogrel solid preparation and preparation method thereof
|
|
CN103172606A
|
|
Coumarin compound with anti-tumor activity
|
|
CN103172745A
|
|
Long-acting human endothelium chalone containing immune globulin Fc segment
|
|
CN103159742A
|
|
5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
|
|
CN103122003A
|
|
Naphthoquinone compound with antitumor activity
|
|
CN103122004A
|
|
Naphthoquinone compound with antitumor activity
|
|
CN103122002A
|
|
Naphthoquinone compound with antitumor activity
|
|
CN102898400A
|
|
GPR119 agonist and application thereof
|
|
CN102807619A
|
|
Compound containing immunoglobulin Fc segment and granulocyte macrophage-colony stimulating factor and pharmaceutical compositions of compound
|
|
CN102730250A
|
|
Device and method for packaging product
|
|
CN102309765A
|
|
Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same
|
|
CN102485743A
|
|
Antineoplastic compound
|
|
CN101993415A
|
|
Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof
|
